LYTIR

Insider · SEC Form 4 · EVP, Research & Investments

Marshall Urist

Filed with the SEC as Urist Marshall; the order above is the one the filer's own signature uses.

In the 12 months to Nov 19, 2026, on the open market: sold $3.2M of RPRX. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $3.2M in total.Jun: Insider sales $502KJul: Insider sales $508KSep: Insider sales $239KOct: Insider sales $236KNov: Insider sales $1.7MDecJanFebMarAprMayJunJulAugSepOctNov$1.7M
Insider purchases above the line: $0Insider sales below: $3.2M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. RPRXSold: Royalty Pharma plc Nov 16, 2026 25,000 shares filed Nov 18, 2026 2 transactions 10b5-1 plan filing $1.7M
  2. RPRXSold: Royalty Pharma plc Oct 5, 2026 4,126 shares filed Oct 5, 2026 0 shares held directly after, as filed 10b5-1 plan filing $236K
  3. RPRXSold: Royalty Pharma plc Sep 28, 2026 4,126 shares filed Sep 30, 2026 4,126 shares held directly after, as filed 10b5-1 plan filing $239K
  4. RPRXSold: Royalty Pharma plc Jul 1, 2026 9,099 shares filed Jul 2, 2026 0 shares held directly after, as filed 10b5-1 plan filing $508K
  5. RPRXSold: Royalty Pharma plc Jun 24, 2026 9,098 shares filed Jun 25, 2026 9,099 shares held directly after, as filed 10b5-1 plan filing $502K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Planned sales (Form 144)

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Notices filed under this filer's SEC CIK in the same 12 months, newest first; the figure is the market value the notice states. Not every notice becomes a sale. Every recent notice

  1. RPRXUrist Marshall filed Oct 5, 2026 Royalty Pharma plc Officer 4,126 shares planned sale date 10/05/2026 filing $236K
  2. RPRXUrist Marshall filed Sep 28, 2026 Royalty Pharma plc Officer 4,126 shares planned sale date 09/28/2026 filing $239K

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • RPRX: grant or award (code A), 2 entries, Aug 5 to Nov 4, 2026
  • RPRX: conversion (code C), 1 entry, Nov 6, 2026
Code A
A grant or award from the company, such as stock given as pay.
Code C
A conversion of a derivative security, such as preferred stock or units, into shares.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.